In-Licensing of novel activin E antibody underscores iBio’s commitment to delivering meaningful benefits to patients living ...

A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

The startup, Veraxa, has $253 million in cash and is raising a crossover funding round to support a pipeline of T cell ...

Belfast firm to partner with QUB to develop humanised therapeutic antibody to combat treatment-resistant cancers ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

Dutch biotech Avidicure has launched with $50 million in seed financing to support development of a novel class of ...

Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical modelsAnti-IL1RAP ADC targets IL1RAP, which is overexpressed in many tumors and their tumor microenvironm ...

Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and ...

Y-mAbs Therapeutics (YMAB) stock drops as Bank of America downgrades the company citing challenges for its only approved drug ...